Morgan Stanley lowered the firm’s price target on Ryan Specialty (RYAN) to $65 from $68 and keeps an Overweight rating on the shares. The firm said that, broadly speaking, commercial property and casualty continues to face growth headwinds from the commercial property pricing slowdown in both primary and reinsurance sub-sectors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- 3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
- Ryan Specialty upgraded to Overweight from Equal Weight at Wells Fargo
- Wolfe Research launches coverage with positive view on Life Insurance names
- Ryan Specialty assumed with Outperform from Peer Perform at Wolfe Research
- Ryan Specialty Group Appoints Michael Bungert to Board